These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37. Krizova P; Musilek M Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519 [TBL] [Abstract][Full Text] [Related]
3. Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci. Poolman JT; Beuvery EC; Hopman CT; Witvliet MH; Timmermans HA; Teerlink T; Zanen HC Dev Biol Stand; 1986; 63():147-52. PubMed ID: 3091433 [TBL] [Abstract][Full Text] [Related]
4. Control of meningococcal meningitis with meningococcal vaccines. Artenstein MS Yale J Biol Med; 1975 Jul; 48(3):197-200. PubMed ID: 808913 [TBL] [Abstract][Full Text] [Related]
5. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613 [TBL] [Abstract][Full Text] [Related]
6. An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine. Rosenqvist E; Tjade T; Frøholm LO; Frasch CE NIPH Ann; 1983 Dec; 6(2):139-49. PubMed ID: 6427704 [TBL] [Abstract][Full Text] [Related]
8. [Humoral immune response to the proteins of an antimeningococcal BC vaccine in a trial carried out in Antioquia, Colombia]. Echeverry Uribe ML; Malberty Agüero JA; Galeano Marín LA; Sotolongo Padrón FT; Galguera Domínguez MA; Montoya Barrientos CM; Blanco González R; Martínez Ruiz O; Martínez Fernández OM; Aguirre Muñoz CA Bol Oficina Sanit Panam; 1995 Apr; 118(4):285-94. PubMed ID: 7779283 [TBL] [Abstract][Full Text] [Related]
9. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine. Milagres LG; Gorla MC; Rebelo MC; Barroso DE FEMS Immunol Med Microbiol; 2000 Aug; 28(4):319-27. PubMed ID: 10891656 [TBL] [Abstract][Full Text] [Related]
10. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. Fredriksen JH; Rosenqvist E; Wedege E; Bryn K; Bjune G; Frøholm LO; Lindbak AK; Møgster B; Namork E; Rye U NIPH Ann; 1991 Dec; 14(2):67-79; discussion 79-80. PubMed ID: 1812438 [TBL] [Abstract][Full Text] [Related]
11. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy. McCormick JB; Gusmão HH; Nakamura S; Freire JB; Veras J; Gorman G; Feeley JC; Wingo P J Clin Invest; 1980 May; 65(5):1141-4. PubMed ID: 6767739 [TBL] [Abstract][Full Text] [Related]
12. Meningococcal meningitis in children: clinical comparison of disease produced by the minor and major serologic groups of Neisseria meningitidis. Ryan NJ; Hogan GR; Bonner MC South Med J; 1984 Oct; 77(10):1234-9. PubMed ID: 6435254 [TBL] [Abstract][Full Text] [Related]
13. Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand. Lennon D; Jackson C; Wong S; Horsfall M; Stewart J; Reid S Clin Infect Dis; 2009 Aug; 49(4):597-605. PubMed ID: 19622040 [TBL] [Abstract][Full Text] [Related]
14. Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica. Kremastinou J; Tzanakaki G; Pagalis A; Theodondou M; Weir DM; Blackwell CC FEMS Immunol Med Microbiol; 1999 May; 24(1):73-8. PubMed ID: 10340715 [TBL] [Abstract][Full Text] [Related]
15. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine. Carmenate T; Guirola M; Alvarez A; Canaán L; González S; Caballero E; Menéndez T; Guillén G FEMS Immunol Med Microbiol; 2005 Feb; 43(2):133-40. PubMed ID: 15681142 [TBL] [Abstract][Full Text] [Related]
16. Prevention of meningococcal serogroup B infections in children: a protein-based vaccine induces immunologic memory. de Kleijn ED; de Groot R; Lafeber AB; Labadie J; van Limpt CJ; Visser J; Berbers GA; van Alphen L; Rümke HC J Infect Dis; 2001 Jul; 184(1):98-102. PubMed ID: 11398116 [TBL] [Abstract][Full Text] [Related]
17. Recent results on epidemic meningococcal meningitis. Achtman M; Crowe BA; Olyhoek A; Strittmatter W; Morelli G J Med Microbiol; 1988 Jul; 26(3):172-7. PubMed ID: 3134549 [No Abstract] [Full Text] [Related]
18. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313 [TBL] [Abstract][Full Text] [Related]
19. Serotypes of Neisseria meningitidis associated with an increased incidence of meningitis cases in the Hamilton area, Ontario, during 1978 and 1979. Ashton FE; Ryan JA; Jones C; Brodeur BR; Diena BB Can J Microbiol; 1983 Jan; 29(1):129-36. PubMed ID: 6403211 [TBL] [Abstract][Full Text] [Related]
20. SDS-PAGE analysis of membrane proteins of group A Neisseria meningitidis isolated before and during an epidemic of group A meningococcal disease in northern Nigeria. Hassan-King M; Greenwood BM Trans R Soc Trop Med Hyg; 1987; 81(1):11-3. PubMed ID: 3127952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]